Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tyk 2 Inhibitors

Tyk 2 inhibitors belong to a distinct chemical class of compounds that exhibit a remarkable capacity to modulate specific cellular signaling pathways, particularly those associated with immune responses and inflammatory processes. These inhibitors target and selectively inhibit Tyrosine Kinase 2 (Tyk 2), a member of the Janus Kinase (JAK) family of intracellular enzymes. Tyk 2 plays a pivotal role in transmitting signals from various cytokine receptors, which are integral to the immune system's communication network. By intervening in these signaling cascades, Tyk 2 inhibitors have the ability to exert significant control over the immune system's activities, offering a promising avenue for pharmacological intervention.

The structural design of Tyk 2 inhibitors is carefully tailored to interact with the active site of the Tyk 2 enzyme, thereby impeding its kinase activity. This interaction disrupts downstream signaling events, leading to the modulation of cytokine-mediated responses. The chemical scaffold of Tyk 2 inhibitors often encompasses unique motifs that allow for the necessary binding interactions while maintaining selectivity against other kinases within the JAK family. This specificity is crucial to mitigate off-target effects and adverse reactions. Through their intricate molecular mechanisms, Tyk 2 inhibitors showcase the ability to fine-tune immune responses and inflammation, although their broader implications and mechanisms beyond their biochemical activity warrant further investigation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Baricitinib

1187594-09-7sc-364730
sc-364730A
5 mg
25 mg
$200.00
$664.00
(1)

Baricitinib inhibits TYK2 by competing with ATP, thereby blocking the phosphorylation of STATs, which leads to reduced cytokine signaling in inflammatory pathways.